Ming Yao

1.1k total citations
35 papers, 481 citations indexed

About

Ming Yao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ming Yao has authored 35 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Ming Yao's work include Cancer Genomics and Diagnostics (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Ming Yao is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Ming Yao collaborates with scholars based in China and United States. Ming Yao's co-authors include Kai Wang, Kai Wang, Aodi Wang, Songhui Zhao, Hui Chen, Xiaowei Dong, Duoguang Wu, Wenjian Wang, Yanfei Yu and Juan Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Ming Yao

32 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Yao China 12 287 217 156 155 128 35 481
Margarita Reboredo Spain 13 304 1.1× 156 0.7× 204 1.3× 206 1.3× 72 0.6× 31 553
Tomoki Taira Japan 15 277 1.0× 260 1.2× 183 1.2× 169 1.1× 144 1.1× 29 537
Ryo Sugimoto Japan 12 199 0.7× 166 0.8× 115 0.7× 97 0.6× 136 1.1× 58 440
Taekyu Lim South Korea 10 329 1.1× 157 0.7× 140 0.9× 124 0.8× 72 0.6× 14 470
Nishi Kothari United States 12 238 0.8× 155 0.7× 74 0.5× 93 0.6× 70 0.5× 29 372
Fabiana Bettoni Brazil 15 273 1.0× 149 0.7× 173 1.1× 247 1.6× 113 0.9× 30 557
Takayuki Takahama Japan 14 265 0.9× 267 1.2× 150 1.0× 125 0.8× 52 0.4× 45 473
Wing P. Chak Hong Kong 4 181 0.6× 292 1.3× 150 1.0× 253 1.6× 85 0.7× 5 522
Céline Gavoille France 8 234 0.8× 106 0.5× 174 1.1× 91 0.6× 42 0.3× 27 344
Irfan Firdaus United States 9 303 1.1× 185 0.9× 50 0.3× 214 1.4× 84 0.7× 15 479

Countries citing papers authored by Ming Yao

Since Specialization
Citations

This map shows the geographic impact of Ming Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Yao more than expected).

Fields of papers citing papers by Ming Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Yao. The network helps show where Ming Yao may publish in the future.

Co-authorship network of co-authors of Ming Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Yao. A scholar is included among the top collaborators of Ming Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Yao. Ming Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Yao, Ming Yao, Chuang Wang, et al.. (2025). GEFormer: A genotype-environment interaction-based genomic prediction method that integrates the gating multilayer perceptron and linear attention mechanisms. Molecular Plant. 18(3). 527–549. 6 indexed citations
3.
Huang, Huihuang, et al.. (2025). The Three-Dimensional Transient Simulation of Cross-Shaped Grains in Hybrid Rocket Motors. Aerospace. 12(5). 429–429.
4.
Simhadri, Srilatha, Stephanie L. Murphy, Atul Kulkarni, et al.. (2024). Evolution of Rapid Clonal Dynamics and Non–Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer. JCO Precision Oncology. 8(8). e2300260–e2300260. 1 indexed citations
6.
Yu, Pengfei, Yusheng Wang, Yanfei Yu, et al.. (2021). Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma. The Oncologist. 26(5). e756–e768. 14 indexed citations
7.
Feng, Weineng, Weiwang Gu, Yiyu Lu, et al.. (2021). P76.77 Combination of EGFR-TKIs with Chemotherapy versus EGFR-TKIs alone in EGFR-Mutant Advanced NSCLC with Concomitant Genetic Alterations. Journal of Thoracic Oncology. 16(3). S622–S622. 1 indexed citations
9.
Tong, Zhou, Yuan Dong, Ming Yao, et al.. (2020). Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine. BMC Medical Genomics. 13(1). 138–138. 10 indexed citations
10.
Hu, Jing, Yu Wang, Yuan Zhang, et al.. (2019). Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential. Cancer Medicine. 8(9). 4338–4347. 45 indexed citations
11.
Guan, Yan, Yan Li, Honglin Guo, et al.. (2019). Effectiveness of EGFR-TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR-RAD51 Fusion. The Oncologist. 24(8). 1027–1030. 11 indexed citations
12.
Fu, Wanyi, et al.. (2019). Comprehensive genomic profiling of Chinese esophageal squamous cell carcinoma patients. Annals of Oncology. 30. i12–i12. 1 indexed citations
13.
Cui, Qiang, et al.. (2019). A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome‐associated lung and gastric double primary cancer patient. Molecular Genetics & Genomic Medicine. 7(8). e787–e787. 5 indexed citations
14.
Song, Chun‐Qing, Junping Shi, Ming Yao, et al.. (2018). Next-Generation Sequencing Assisted in Establishing the Diagnosis and Treatment for a Chinese Patient With Breast and Lung Multiple Primary Malignancies. Journal of Thoracic Oncology. 13(7). e109–e111. 1 indexed citations
15.
Ling, Qi, Xinglong Wu, Yang Shen, et al.. (2018). The landscape of NTRK fusions in Chinese patients with solid tumor. Annals of Oncology. 29. viii22–viii23. 12 indexed citations
17.
Ali, Siraj M., Ming Yao, Jicheng Yao, et al.. (2017). Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy. Cancer. 123(18). 3628–3637. 36 indexed citations
18.
Zhang, Xuefei, Yan-Lin Li, Weifeng Wang, et al.. (2017). Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing. Lung Cancer. 118. 27–29. 14 indexed citations
19.
Shou, Tao, Yunfei Shi, Qisen Guo, et al.. (2017). The landscape of kinase fusions in 445 Chinese NSCLC patients. Annals of Oncology. 28. vii16–vii16. 1 indexed citations
20.
Bilal, Erhan, Gabriela Alexe, Ming Yao, et al.. (2010). Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers. Genes & Cancer. 1(10). 1063–1073. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026